Bucog, Joel Greg T.
HRN: 02-89-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2024
CEFTAZIDIME 1GM (VIAL)
06/28/2024
07/05/2024
IV
1g
Q8H
Fistula In Ano
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes